Immunome, Inc.IMNMNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank14
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-214.11M
↓ 137% vs avg
Percentile
P14
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-90.24M
Historical baseline
PeriodValueYoY Change
2025$-214.11M+30.0%
2024$-305.80M-179.2%
2023$-109.53M-196.8%
2022$-36.90M-46.4%
2021$-25.20M-105.6%
2020$-12.26M-18.5%
2019$-10.35M-33.6%
2018$-7.74M-